Hansa Biopharma — Juli 2022

[ProinvestorNEWS]

Video med TA-analyse af
XBI,
Bavarian,
Novo Nordisk,
Genmab,
Zealand Pharma og
Hansa Biopharma. https://www.proinvestor.com/boards/104411/

[ProinvestorNEWS]

Previews from ABG and SEB ahead of Q2, which will be reported July 19, 2022 at 8am CET

Consensus is also updated on the link below

https://investors.hansabiopharma.com/English/stock-information/analyst-consensus/default.aspx

[LP90]

kunne være rart hvis vi bare kunne komme i nærheden af de meget positive targets der er i markedet syntes godt nok det er en max langtrækker

[exitnu]

D.d. Hansa Biopharma Analyst Consensus Price target: SEK 230 (Median)
Recommendations: Buy: 11 - Hold: 0 - Sell: 0

[exitnu]

JA, ting tager tid - især i biotek. Jeg venter gerne på de gode nyheder

[Jazzz]

Alt ser godt ud for Hansa.. men som de selv siger 18-24 mdr før vi ser noget der rigtigt rykker.. tålmodighed er en dyd.

[exitnu]

Enig

[rolling]

Enig med jer begge. Det er et super stof hansa har udviklet..Mange muligheder i mange indikationer

[exitnu]

Hansa Biopharma announces $70 million non-dilutive product finance transaction with NovaQuest to support continued development of the company’s antibody-cleaving enzyme technology platform

https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2022/Hansa-Biopharma-announces-70-million-non-dilutive-product-finance-transaction-with-NovaQuest-to-support-continued-development-of-the-companys-antibody-cleaving-enzyme-technology-platform/default.aspx

[exitnu]

"Proceeds will be mainly utilized to:

Further strengthen the Company’s position in kidney transplantation through the continued support of ongoing European commercial launch activities for Idefirix (imlifidase) and execution of the U.S. ConfIdeS trial of imlifidase, which is expected to support a potential Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) under the accelerated approval pathway in the first half of 2024. In addition, Hansa will advanc

[exitnu]

.... In addition, Hansa will advance the global Phase 3 clinical trial of imlifidase in anti-GBM antibody disease and ongoing clinical programs in other indications"

[Helge_LarsenPI-redaktør]

Fra debatteb: https://www.proinvestor.com/boards/104550/

[exitnu]

Hansa Biopharma AB: Hansa Biopharma half year report 2022

Hansa Biopharma half year report 2022

•    Continued solid sales in Q2 •    Positive NICE recommendation obtained  •    Completed

News Powered by Cision (news.cision.com)

[exitnu]

TUE, JUL 19, 2022 08:00

• Continued solid sales in Q2

• Positive NICE recommendation obtained

• Completed enrollment in imlifidase Phase 2 program in AMR

• Peter Nicklin elected as new Chairman of the Board of Directors

[Jazzz]

Gode meldinger over hele linien. Voldsomt spændende aktie med en meget rimelig risk-benefit. Ikke så tit man finder dem.

[exitnu]

"Start of Volatility Halt Auction Period: Order book 'HNSA' in market 'STO Equities CCP' at 10:06:11.879"

[exitnu]

Tilsyneladende har markedet taget ret positivt imod halvårsrapporten

[Stroka]

Jeg sidder med et mega papirtab i aktien. Har været lige ved at tage tabet mange gang siden nedturen for alvor startede. Det gør jeg så ikke nu.

[exitnu]

Husk CC idag kl. 14:00.

The webcast will be available on:

Page Not Found - streams.eventcdn.net

(streams.eventcdn.net)

[exitnu]

Pænt luk i kurs 79 med stor volumen. 40,95%.

En god dag på kontoret